MKI67 and breast cancer: The expression of proliferation-related genes in BC is linked to more aggressive subtypes (luminal B and non-luminal subtypes) and forms the foundation for the recent inclusion of clinical KI67 determinations as a predictive and prognostic immunohistochemical (IHC) marker (17).